Tilia Fiduciary Partners’s Pfizer PFE Stock Holding History

Tilia Fiduciary Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-4,360	Closed	-$160K	–	360
2023 Q2	$160K	Buy	4,360 +1,675	+62%	+$65.2K	0.14%	100
2023 Q1	$110K	Sell	2,685 -564	-17%	-$24.4K	0.1%	126
2022 Q4	$166K	Sell	3,249 -35	-1%	-$1.68K	0.16%	104
2022 Q3	$138K	Sell	3,284 -103	-3%	-$5K	0.14%	112
2022 Q2	$176K	Buy	3,387 +3	+0.1%	+$153	0.17%	99
2022 Q1	$175K	Buy	3,384 +428	+14%	+$22.2K	0.15%	111
2021 Q4	$175K	Buy	+2,956	New	+$146K	0.14%	110

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Tilia Fiduciary Partners's PFE Position: Q3 2023 in Review

Tilia Fiduciary Partners sold out of Pfizer (PFE) in Q3 2023, closing a stake of 4,360 shares — an estimated $160K sold.

Tilia Fiduciary Partners first reported a position in PFE in Q4 2021 and held it in 7 quarters. The position peaked at $176K in Q2 2022. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

Tilia Fiduciary Partners reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
Tilia Fiduciary Partners sold 4,360 Pfizer shares in Q3 2023, an estimated $160K.
Tilia Fiduciary Partners first reported a position in Pfizer in Q4 2021 and held it in 7 quarters.
Tilia Fiduciary Partners's Pfizer position peaked at $176K in Q2 2022.
2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Tilia Fiduciary Partners's 13F filing for Q3 2023, filed 10 Oct 2023.